Cubist Pharmaceuticals CEO Michael Bonney: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Exec discusses the development and eventual approval of the first-in-class antibiotic Cubicin.